Neuropathy Associated with Systemic Amyloidosis.
Kaku M, Berk JL.
Semin Neurol. 2019 Oct;39(5):578-588. doi: 10.1055/s-0039-1688994. Epub 2019 Oct 22.
Paraproteinemia and neuropathy.
Koike H, Katsuno M.
Neurol Sci. 2021 Nov;42(11):4489-4501. doi: 10.1007/s10072-021-05583-7. Epub 2021 Sep 16.
Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J, Nakashima M, Wong S.
JAMA Oncol. 2021 Sep 1;7(9):1383-1391. doi: 10.1001/jamaoncol.2021.0586.
IgM monoclonal gammopathies of clinical significance: diagnosis and management.
Khwaja J, D'Sa S, Minnema MC, Kersten MJ, Wechalekar A, Vos JM.
Haematologica. 2022 Sep 1;107(9):2037-2050. doi: 10.3324/haematol.2022.280953.
POEMS syndrome: clinical update.
Brown R, Ginsberg L.
J Neurol. 2019 Jan;266(1):268-277. doi: 10.1007/s00415-018-9110-6. Epub 2018 Nov 29.
Paraproteinemia and neuropathy.
Simmons Z.
Curr Opin Neurol. 1999 Oct;12(5):589-95. doi: 10.1097/00019052-199910000-00013.
Paraproteinemic neuropathies.
Traub R, Qarni T, Cohen AD, Karam C.
Muscle Nerve. 2024 Aug;70(2):173-179. doi: 10.1002/mus.28164. Epub 2024 May 30.
Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis.
Chompoopong P, Almarwani B, Katirji B.
J Neurol Sci. 2021 Mar 15;422:117336. doi: 10.1016/j.jns.2021.117336. Epub 2021 Feb 6.
Neuropathies associated with paraproteinemia.
Ropper AH, Gorson KC.
N Engl J Med. 1998 May 28;338(22):1601-7. doi: 10.1056/NEJM199805283382207.
Paraproteinemic Neuropathies.
Beydoun SR, Darki L.
Continuum (Minneap Minn). 2023 Oct 1;29(5):1492-1513. doi: 10.1212/CON.0000000000001294.
